Market revenue in 2023 | USD 274.2 million |
Market revenue in 2030 | USD 537.4 million |
Growth rate | 10.1% (CAGR from 2023 to 2030) |
Largest segment | Adult stem cells |
Fastest growing segment | Induced Pluripotent Stem Cells |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.7% in 2023. Horizon Databook has segmented the Italy stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Italy has a strong connection between scientists and clinicians, thus possessing strong clinical capacity in the early stages of clinical testing. Out of 10 gene therapy products approved in Europe, 3 have been developed in Italy.
Out of 6 commercially available gene and cell therapy products, Italy contributed to half. Positive outcomes of Strimvelis had resulted in increasing investments in cell and gene therapy research in the country. This indicates its significant contributions to advanced therapy products.
Furthermore, in June 2022, professionals from Japan and Italy in neuroscience hosted a webinar to demonstrate the research of both regions on the use of regenerative medicines and stem cells for neurological repair. Such collaborations are anticipated to favor market growth in the coming years.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Italy stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account